drugset / Trial / NCT02447796
Dexmedetomidine and Propofol As Sole Sedative Agent for Patients Undergoing Arteriovenous Fistula Surgery
RandomizedParallel-groupDouble-blindTreatment
Summary
The investigators designed a prospective randomized study to compare the conventionally used sedative drug propofol with a latest alternative dexmedetomidine (DEX), in patients with end-stage renal disease undergoing arteriovenous fistula (AVF) surgery.
Timeline
- Start
- 2015-05
- Primary completion
- 2015-05
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 1 ug/kg | — |
| Comparator | Dexmedetomidine | Other / unclassified | 1.5 ug/kg | — |
| Comparator | Propofol | Small molecule | 1 mg/kg | — |
| Comparator | Propofol | Small molecule | 1.5 mg/kg | — |